Percheron Therapeutics Limited
PERCF
$0.0025
-$0.0165-86.84%
OTC PK
| 12/31/2024 | 09/30/2024 | ||||
|---|---|---|---|---|---|
| Revenue | -- | -- | |||
| Total Other Revenue | -2.75% | 112.87% | |||
| Total Revenue | -2.75% | -91.26% | |||
| Cost of Revenue | -2.79% | 412.70% | |||
| Gross Profit | -2.69% | -96.77% | |||
| SG&A Expenses | -2.74% | 3.01% | |||
| Depreciation & Amortization | -2.48% | 14.15% | |||
| Other Operating Expenses | -- | -- | |||
| Total Operating Expenses | -2.75% | -2.06% | |||
| Operating Income | 2.75% | -19.93% | |||
| Income Before Tax | 2.75% | -20.95% | |||
| Income Tax Expenses | -- | -- | |||
| Earnings from Continuing Operations | 2.75% | -20.95% | |||
| Earnings from Discontinued Operations | -- | -- | |||
| Extraordinary Item & Accounting Change | -- | -- | |||
| Minority Interest in Earnings | -- | -- | |||
| Net Income | 2.75% | -20.95% | |||
| EBIT | 2.75% | -19.93% | |||
| EBITDA | 2.75% | -19.51% | |||
| EPS Basic | 3.23% | -34.78% | |||
| Normalized Basic EPS | 0.00% | -35.71% | |||
| EPS Diluted | 3.23% | -34.78% | |||
| Normalized Diluted EPS | 0.00% | -35.71% | |||
| Average Basic Shares Outstanding | 0.00% | -10.24% | |||
| Average Diluted Shares Outstanding | 0.00% | -10.24% | |||
| Dividend Per Share | -- | -- | |||
| Payout Ratio | -- | -- | |||